Open Label, Single Arm Safety Prospective Cohort Study of Dabigatran Etexilate for Secondary Prevention of Venous Thromboembolism in Children From 0 to Less Than 18 Years
收藏DataCite Commons2025-04-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007357/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This open-label, single arm prospective cohort study will assess the safety of dabigatran
etexilate in secondary prevention of venous thromboembolism in paediatric patients. Children
from 0 to less than 18 years of age will be eligible to participate.
提供机构：
Vivli
创建时间：
2021-08-25
